Business Wire

HAUSFELD-&-CO-LLP

22.2.2021 09:02:10 CET | Business Wire | Pressemeddelelse

Del
Det britiske konkurrenceankenævn, Competition Appeal Tribunal, skal behandle to begæringer om kollektive søgsmål, som omhandler valutahandelskarteller

Fra 12. til 16. juli 2021 vil Competition Appeal Tribunal (CAT) tage stilling til, hvorvidt det skal godkende en begæring om kollektivt søgsmål/gruppesøgsmål (FX Claim UK ) indbragt af Phillip Evans, repræsentant for gruppen og tidligere formand for undersøgelseskomitéen ved den britiske Competition and Markets Authority. Søgsmålet er rettet mod enheder, der indgår i følgende bankkoncerner: Barclays, Citibank, The Royal Bank of Scotland/NatWest, JPMorgan, UBS og MUFG Bank.

Hver af bankerne har indrømmet overtrædelser af EU's konkurrencelovgivning i forbindelse med spothandel med valuta. Phillip Evans’ foreslåede krav søger kompensation fra bankerne på vegne af foreslåede grupper af personer, som hævdes at have lidt tab som følge af bankernes deltagelse i de pågældende overtrædelser.

CAT har udstedt en bekendtgørelse vedrørende dette retsmøde, som kan findes her .

Phillip Evans har engageret Hausfeld & Co LLP, et førende advokatfirma inden for tvister og konflikter, til at føre sagen. Hausfeld & Co LLP’s amerikanske søsterselskab, Hausfeld LLP, er et af de førende advokatfirmaerne i et lignende kollektivt søgsmål i USA, der inddrev mere end 2,3 mia. USD til personer, som var blevet berørt af overtrædelser mht. valutahandel i USA.

Phillip Evans' begæring anmoder CAT om at godkende kravet som kvalificeret til at fortsætte som kollektivt søgsmål på vegne af berettigede enheder og enkeltpersoner samt at godkende, at Phillip Evans agerer som repræsentant for gruppen.

CAT behandler Phillip Evans' begæring samtidigt med en anden begæring om kollektivt søgsmål relateret til valutahandelskarteller, der er fremsat af Michael O’Higgins FX Class Representative Limited. Det betyder, at CAT skal afgøre, hvilken af repræsentanterne der er bedst egnet til at handle som repræsentant for gruppen. Dette er første gang, at CAT er blevet bedt om at afklare en tvist af denne type i relation til kollektive søgsmål.

Enhver person med interesse i de to begæringer (herunder foreslåede medlemmer af gruppen) kan gøre indsigelse mod en af eller begge begæringerne eller bemyndigelsen af en af eller begge foreslåede repræsentanter ved at kontakte CAT og angive deres grunde til at gøre indsigelse senest kl. 16.00 den 4. maj 2021. Disse personer kan også anmode om tilladelse til at fremsætte skriftlige og/eller mundtlige bemærkninger under retsmødet i juli ved at sende en ansøgning herom, understøttet med begrundelser, til domstolen senest kl. 16.00 den 4. maj 2021.

Phillip Evans udtaler: "Det er i gruppens medlemmers interesse, at spørgsmål om certificering og valg af repræsentant afgøres så hurtigt som muligt. Det glæder mig, at domstolen har besluttet at afholde retsmødet om certificeringen i juli 2021."

Med forbehold for eventuelle ændringer som følge af Covid-19-pandemien vil retsmødet finde sted i Competition Appeal Tribunal, Salisbury Square House, 8 Salisbury Square, London EC4Y 8AP. For oplysninger om, hvordan du deltager i domstolens behandling af de to begæringer ved at aflevere skriftlige bemærkninger eller for at ansøge om at blive hørt ved retsmødet i juli, skal du gå ind på www.fxclaimuk.com og læse CATs bekendtgørelse her .

Slut

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

AV Access Presents eShare W90: A 4K Wireless Conferencing System for Smarter Hybrid Meetings at ISE 2026 in Barcelona28.1.2026 09:00:00 CET | Press release

AV Access proudly announces its participation in ISE 2026, one of the world’s leading AV and systems integration exhibitions. From February 3-6 at the Fira de Barcelona, Gran Via, the company will showcase its latest solutions designed to improve collaboration, enhance entertainment, and boost workplace productivity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260128178621/en/ The eShare W90 wireless presentation and conferencing system makes hybrid meetings more secure, more collaborative, and far easier to manage. At Booth 1F110, AV Access will highlight its flagship innovations, including the eShare W90 wireless conferencing system, the plug-and-play 4KIP200 HDMI over IP solution, and the complete iDock series of KVM docking stations—demonstrating its dedication to versatile, high-performance AV technology. Stream, Charge and Share with a Single USB-C Cable At the heart of the booth is the eShare W90 wireless presentat

SES Extends EGNOS GEO-1 Satellite Service to Power Precise Navigation Across Europe28.1.2026 08:50:00 CET | Press release

The agreement ensures Europe’s satellite-based augmentation continues enhancing navigation for aviation and other critical users and lowering emissions SES, a leading space solutions company, and the European Union Agency for the Space Programme (EUSPA) today announced an extension of the European Geostationary Navigation Overlay Service (EGNOS) GEO-1 satellite service agreement through 2030, with an option to extend until 2032, helping maintain high-precision navigation services for aviation and other critical users across Europe. By improving the accuracy and integrity of satellite positioning signals, EGNOS supports aircraft in landing in low-visibility conditions, as well as planning more efficient routes, reducing fuel burn and CO₂ emissions. At the core of the EGNOS service is Europe’s regional Satellite-Based Augmentation System (SBAS) that improves the accuracy and reliability of Global Navigation Satellite System (GNSS) signals, such as GPS. Beyond aviation, EGNOS supports mar

LTTS Secures Strategic Engineering and R&D Agreement from Global Automotive OEM28.1.2026 08:30:00 CET | Press release

Key win in LTTS’ Mobility Segment across multiple vehicle technology domains L&T Technology Services (BSE: 540115, NSE: LTTS), a global leader in AI, Digital & ER&D Consulting Services, announced that it has secured a significant multi-year engagement in its Mobility segment from a leading automotive OEM. The strategic win further strengthens LTTS’ long-standing partnership with the premium automotive manufacturer and underscores its growing role in supporting next-generation mobility engineering. The engagement encompasses advanced software, connectivity and digital engineering services across multiple vehicle technology domains. LTTS will draw on its global engineering expertise, strong domain knowledge and proven delivery frameworks to support the customer’s evolving product and technology roadmap. This win reinforces LTTS’ comprehensive mobility engineering capabilities, spanning embedded systems, digital platforms, verification and validation, cloud integration, cybersecurity, and

SFI Health™ EMEA Announces the Launch in Poland of Equazen® Forte, Marking a New Chapter in Cognitive Support for Young Adults and Adults28.1.2026 08:00:00 CET | Press release

Equazen® Forte represents a strategic evolution of the brand, extending its clinically researched omega-3 based cognitive support product formulation beyond children to young adults and adults through pharmacies across Poland. SFI Health™ EMEA, the regional entity of SFI Health™, a global leader in natural healthcare, today is pleased to announce the launch of Equazen® Forte in Poland, a new concentrated omega 3 product formulation to be added to the Equazen® range designed to support the normal cognitive performance for young adults and adults. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260127646023/en/ Equazen® Forte: a key milestone in the brand’s long-term development strategy. Equazen® Forte represents a key milestone in the brand’s long-term development strategy. Traditionally recognized as a pediatric brain health expert, Equazen® is now evolving to support consumers across different life stages, addressing changi

Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G pTau 217 CSF Assay for Research Use Only28.1.2026 07:07:00 CET | Press release

H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 CSF assay for the fully automated LUMIPULSE® G immunoassay analyzers. This CLEIA (chemiluminescent enzyme immunoassay) assay is available for Research Use Only (RUO) and allows for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human cerebrospinal fluid (CSF) within just 35 minutes. Alzheimer’s disease (AD) is characterized by the accumulation of neurofibrillary tangles in the brain, composed of hyperphosphorylated tau, and amyloid plaques, consisting of distinct β-amyloid peptides. CSF pTau217 has emerged as an early biomarker for neuropathological changes associated with AD. This new immunoassay further strengthens Fujirebio’s growing portfolio of neurological biomarkers and reinforces the company’s leading position in the advancement of associated research tools and diagnostics. “By adding pTau 217 CSF to our neuro portfol

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye